STEPWISE – STructured lifestyle Education for People WIth SchizophrEnia: a study protocol for a randomised controlled trial
Authors:
- Rebecca Gossage-WorrallRGRebecca Gossage-Worrall
- Richard I. G. HoltRHRichard I. G. Holt
- Katharine BarnardKBKatharine Barnard
- Marian E. CareyMCMarian E. Carey
- Melanie J. DaviesMDMelanie J. Davies
- Chris DickensCDChris Dickens
- Yvonne DohertyYDYvonne Doherty
- Charlotte EdwardsonCECharlotte Edwardson
- Paul FrenchPFPaul French
- Fiona GaughranFGFiona Gaughran
- Kathryn GreenwoodKGKathryn Greenwood
- Sridevi KalidindiSKSridevi Kalidindi
Open Access
- 29 September 2016
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 17 (1) , 475
Abstract
People with schizophrenia are two to three times more likely to be overweight than the general population. The UK National Institute of Health and Care Excellence (NICE) recommends an annual physical health review with signposting to, or provision of, a lifestyle programme to address weight concerns and obesity. The purpose of this randomised controlled trial is to assess whether a group-based structured education programme can help people with schizophrenia to lose weight. Design: a randomised controlled trial of a group-based structured education programme. Setting: 10 UK community mental health trusts. Participants: 396 adults with schizophrenia, schizoaffective, or first-episode psychosis who are prescribed antipsychotic medication will be recruited. Participants will be overweight, obese or be concerned about their weight. Intervention: participants will be randomised to either the intervention or treatment as usual (TAU). The intervention arm will receive TAU plus four 2.5-h weekly sessions of theory-based lifestyle structured group education, with maintenance contact every 2 weeks and ‘booster’ sessions every 3 months. All participants will receive standardised written information about healthy eating, physical activity, alcohol and smoking. Outcomes: the primary outcome is weight (kg) change at 1 year post randomisation. Secondary outcomes, which will be assessed at 3 and 12 months, include: the proportion of participants who maintained or reduced their weight; waist circumference; body mass index; objectively measured physical activity (wrist accelerometer); self-reported diet; blood pressure; fasting plasma glucose, lipid profile and HbA1c (baseline and 1 year only); health-related quality of life (EQ-5D-5L and RAND SF-36); (adapted) brief illness perception questionnaire; the Brief Psychiatric Rating Scale; the Client Service Receipt Inventory; medication use; smoking status; adverse events; depression symptoms (Patient Health Questionnaire-9); use of weight-loss programmes; and session feedback (intervention only). Outcome assessors will be blind to trial group allocation. Qualitative interviews with a subsample of facilitators and invention-arm participants will provide data on intervention feasibility and acceptability. Assessment of intervention fidelity will also be performed. The STEPWISE trial will provide evidence for the clinical and cost-effectiveness of a tailored intervention, which, if successful, could be implemented rapidly in the NHS. ISRCTN19447796 , registered on 20 March 2014.Keywords
Funding Information
- Health Technology Assessment Programme (12/28/05)
This publication has 48 references indexed in Scilit:
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trialsSchizophrenia Research, 2012
- Let’s prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulationCardiovascular Diabetology, 2012
- Validation of the theoretical domains framework for use in behaviour change and implementation researchImplementation Science, 2012
- Comparisons against baseline within randomised groups are often used and can be highly misleadingTrials, 2011
- Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in LondonPLOS ONE, 2011
- Normalisation process theory: a framework for developing, evaluating and implementing complex interventionsBMC Medicine, 2010
- Preventing type 2 diabetes: can we make the evidence work?Postgraduate Medical Journal, 2009
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008
- Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trialBMJ, 2008
- Urbanisation and healthClinical Medicine, 2005